SilverCrest Metals
SILV
Collegium Pharmaceutical
COLL
Cars.com
CARS
Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 14.44%24.89M | 14.58%24.4M | 16.15%24.02M | 26.84%91.79M | 32.94%28.07M | 9.39%21.75M | 29.15%21.29M | 38.94%20.68M | 30.42%72.37M | 43.26%21.11M |
Net interest income | 2.27%21.22M | 3.58%21.23M | 10.02%22.01M | 18.90%82.55M | 4.49%21.3M | 8.93%20.75M | 29.78%20.5M | 40.81%20.01M | 30.41%69.43M | 45.78%20.38M |
-Net interest income | 5.57%33.49M | 7.97%32.44M | 21.57%33.29M | 54.34%121.54M | 27.25%32.4M | 46.24%31.72M | 80.19%30.04M | 83.45%27.38M | 39.90%78.75M | 73.71%25.46M |
-Interest income from loans and lease | 6.62%30.79M | 7.59%28.93M | 18.80%30.12M | 47.63%109.84M | 20.67%28.73M | 41.11%28.88M | 70.66%26.89M | 76.34%25.35M | 33.42%74.4M | 65.42%23.81M |
-Interest income from deposits | 11.32%177K | 296.77%246K | 416.33%253K | 1,028.26%519K | 3,457.14%249K | 1,490.00%159K | 376.92%62K | 206.25%49K | -72.78%46K | -75.00%7K |
-Interest income from securities | -52.31%372K | 30.03%1.02M | 36.82%1.09M | 16.76%3.12M | -1.68%762K | 0.00%780K | 19.82%786K | 71.65%793K | 1,436.21%2.67M | 345.40%775K |
-Other interest income | 12.87%2.15M | -2.90%2.24M | 54.47%1.83M | 395.45%8.06M | 205.04%2.66M | 337.47%1.9M | 827.31%2.31M | 1,594.29%1.19M | 814.04%1.63M | 1,264.06%873K |
-Total interest expense | 11.80%12.27M | 17.39%11.2M | 52.93%11.28M | 318.34%39M | 118.54%11.1M | 314.81%10.98M | 987.02%9.54M | 928.45%7.37M | 205.34%9.32M | 650.52%5.08M |
-Interest expense for deposit | 11.80%12.27M | 17.39%11.2M | 52.93%11.28M | 318.34%39M | 118.54%11.1M | 314.81%10.98M | 987.02%9.54M | 928.45%7.37M | 205.34%9.32M | 650.52%5.08M |
Non interest income | 265.14%3.68M | 298.61%3.17M | 198.81%2.01M | 214.46%9.24M | 824.86%6.77M | 19.88%1.01M | 14.74%794K | -0.44%672K | 30.62%2.94M | -3.30%732K |
-Fees and commissions | 53.42%336K | 8.68%338K | 3.81%300K | -13.42%1.2M | 21.73%381K | -36.34%219K | -0.96%311K | -30.36%289K | 40.71%1.39M | -11.08%313K |
-Other non interest income | 320.75%3.35M | 476.94%2.83M | 344.79%1.71M | 379.64%8.06M | 1,425.06%6.39M | 57.11%795K | 33.15%490K | -0.78%384K | 32.81%1.68M | 3.46%419K |
-Gain loss on sale of assets | 42.86%-4K | --0 | --0 | 87.40%-16K | ---1K | 30.00%-7K | -170.00%-7K | 99.21%-1K | ---127K | --0 |
Credit losses provision | 0 | 0 | 0 | -373.25%-21.15M | -853.85%-15.5M | -77.13%-4.16M | -361.64%-1.01M | -72.10%-475K | -7.02%-4.47M | -91.18%-1.63M |
Non interest expense | 27.17%9.4M | 23.93%9.14M | 19.43%9.14M | 16.69%33.42M | 35.46%11.01M | 3.60%7.39M | 5.95%7.38M | 19.14%7.65M | 40.42%28.64M | 31.07%8.13M |
Occupancy and equipment | 5.79%969K | 10.24%937K | -7.95%891K | -2.98%3.68M | 2.37%949K | -8.76%916K | -11.18%850K | 6.49%968K | 36.48%3.8M | 25.27%927K |
Professional expense and contract services expense | 1,457.14%218K | 47.49%264K | -66.78%99K | -44.82%543K | -74.26%52K | -95.88%14K | -14.35%179K | 27.90%298K | 23.00%984K | -42.78%202K |
Selling and administrative expenses | 9.59%5.46M | 9.24%5.2M | 12.55%5.43M | 1.68%17.81M | -35.91%3.24M | 22.19%4.98M | 12.10%4.76M | 16.73%4.83M | 42.82%17.52M | 48.72%5.06M |
-General and administrative expense | 8.62%5.33M | 8.69%5.12M | 13.01%5.29M | 2.02%17.39M | -36.92%3.09M | 22.87%4.91M | 14.13%4.71M | 16.24%4.68M | 42.20%17.04M | 48.33%4.89M |
-Selling and marketing expense | 74.32%129K | 59.62%83K | -2.03%145K | -10.48%427K | -5.52%154K | -10.84%74K | -57.02%52K | 34.55%148K | 69.15%477K | 61.39%163K |
Other non-interest expense | 86.25%2.75M | 72.65%2.74M | 74.34%2.71M | 79.43%11.38M | 248.53%6.77M | -13.68%1.48M | 2.39%1.59M | 36.16%1.56M | 39.41%6.34M | 13.71%1.94M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | 51.86%15.5M | 18.22%15.26M | 18.55%14.88M | -5.18%37.22M | -86.27%1.56M | -1.92%10.2M | 38.69%12.9M | 53.34%12.55M | 26.99%39.26M | 47.79%11.36M |
Income tax | 58.19%3.72M | 18.14%3.73M | 21.99%3.6M | -6.98%8.95M | -83.48%491K | -0.51%2.35M | 38.51%3.16M | 47.13%2.95M | 24.04%9.62M | 48.50%2.97M |
Earnings from equity interest net of tax | ||||||||||
Net income | 49.97%11.78M | 18.24%11.52M | 17.50%11.29M | -4.60%28.28M | -87.26%1.07M | -2.34%7.85M | 38.75%9.75M | 55.35%9.61M | 27.98%29.64M | 47.54%8.39M |
Net Income continuous operations | 49.97%11.78M | 18.24%11.52M | 17.50%11.29M | -4.60%28.28M | -87.26%1.07M | -2.34%7.85M | 38.75%9.75M | 55.35%9.61M | 27.98%29.64M | 47.54%8.39M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 49.97%11.78M | 18.24%11.52M | 17.50%11.29M | -4.60%28.28M | -87.26%1.07M | -2.34%7.85M | 38.75%9.75M | 55.35%9.61M | 27.98%29.64M | 47.54%8.39M |
Preferred stock dividends | ||||||||||
Other preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 49.97%11.78M | 18.24%11.52M | 17.50%11.29M | -4.60%28.28M | -87.26%1.07M | -2.34%7.85M | 38.75%9.75M | 55.35%9.61M | 27.98%29.64M | 47.54%8.39M |
Basic earnings per share | 46.51%1.26 | 17.92%1.25 | 16.19%1.22 | -5.21%3.09 | -86.96%0.12 | -2.27%0.86 | 37.66%1.06 | 54.41%1.05 | 27.34%3.26 | 46.03%0.92 |
Diluted earnings per share | 45.88%1.24 | 17.14%1.23 | 16.35%1.21 | -5.28%3.05 | -86.81%0.12 | -2.30%0.85 | 38.16%1.05 | 55.22%1.04 | 26.27%3.22 | 44.44%0.91 |
Dividend per share | 14.29%0.24 | 31.25%0.21 | 31.25%0.21 | 42.31%0.74 | 31.25%0.21 | 75.00%0.21 | 33.33%0.16 | 33.33%0.16 | 15.56%0.52 | 33.33%0.16 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |